NewslettersCell Therapy News CAR-T Cell Therapy Targeting Surface Expression of TYRP1 to Treat Cutaneous and Rare Melanoma Subtypes By lbeveridge - February 12, 2024 0 Investigators identified Tyrosinase Related Protein 1 as a CAR-T cell therapy target to treat patients with cutaneous and rare melanoma subtypes unresponsive to immune checkpoint blockade. [Nature Communications] Full Article